AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 APR 2 - (NewsRx.com & NewsRx.net) -- Researchers at the University of Alabama at Birmingham (UAB) are joining the effort to test a vaccine that they hope will keep women from contracting human papillomavirus (HPV), a common infection that is known to cause genital warts and virtually all cases of cervical cancer.
In a study reported last fall in the New England Journal of Medicine, investigators showed that the vaccine prevented the most common type of HPV in 100% of women who took it, whereas 3.8% of those who were not vaccinated developed HPV each year.
"We have high hopes that this vaccine will continue to prove effective against more types of HPV during this next phase of trials," said Dr. Edward Partridge, who heads UAB's gynecological cancer program. "The reason this is important is that we know HPV infects up to 20% of all women and is linked to more than 200,000 cases of cervical cancer every year ...